Second-line rescue treatment of

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

20 citing papers in PubMed, 35 citations in OpenAlex.

1. Efficacy and Safety of Antofloxacin-Based Triple Therapy for Helicobacter pylori Eradication Failure in China.Digestive diseases and sciences · 2022
   Trial
2. Lack of follow-up inWorld journal of gastroenterology · 2026
   Article
3. Nanoemulsion as a promising drug delivery strategy for effective eradication of Helicobacter pylori: current insights.Drug delivery and translational research · 2026
   Review
4. The interval of rescue treatment does not affect the efficacy and safety of Helicobacter pylori eradication: A prospective multicenter observational study.Chinese medical journal · 2025
   Observational
5. Efficacy and tolerability ofHealth science reports · 2024
   Article
6. Microorganisms · 2024
   Review
7. Helicobacter pylori in the post-antibiotics era: from virulence factors to new drug targets and therapeutic agents.Archives of microbiology · 2023
   Review
8. Study of the Effect of Baicalin fromInternational journal of molecular sciences · 2023
   Article
9. Efficacy and safety of modified tetracycline dosing in a quadruple therapy forWorld journal of gastroenterology · 2023
   Article
10. Management ofJGH open : an open access journal of gastroenterology and hepatology · 2023
    Review
11. Egg yolk antibody combined with bismuth-based quadruple therapy inFrontiers in microbiology · 2023
    Article
12. Eradication rate and safety of a "simplified rescue therapy": 14-day vonoprazan and amoxicillin dual regimen as rescue therapy on treatment of Helicobacter pylori infection previously failed in eradication: A real-world, retrospective clinical study in China.Helicobacter · 2022
    Article
13. Therapeutic Potential of Sitafloxacin as a New Drug Candidate forAntibiotics (Basel, Switzerland) · 2021
    Article
14. Clinical Relevance ofJournal of clinical medicine · 2021
    Review
15. Cost-effectiveness modelling of use of urea breath test for the management ofBMJ open gastroenterology · 2021
    Article
16. Helicobacter pylori treatment in the post-antibiotics era-searching for new drug targets.Applied microbiology and biotechnology · 2020
    Review
17. Tailored eradicationWorld journal of gastroenterology · 2019
    Article
18. Molecular mechanism ofOncology letters · 2019
    Review
19. Development ofWorld journal of gastroenterology · 2019
    Review
20. High Eradication Rate of a Potassium-Competitive Acid Blocker-Based Minocycline, Furazolidone, and Bismuth Regimen for Refractory Helicobacter pylori Infection: A Real-World Study.Helicobacter
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as